Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NVAX NASDAQ:WKME On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVAXNovavax$10.11+9.5%$9.05$5.80▼$11.97$1.66B2.374.01 million shs13.32 million shsWKMEWalkMe$13.95$13.90$7.60▼$14.09$1.21B0.16438,095 shsN/ATen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVAXNovavax+9.53%+25.75%+18.38%+22.55%+69.92%WKMEWalkMe0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVAXNovavax$10.11+9.5%$9.05$5.80▼$11.97$1.66B2.374.01 million shs13.32 million shsWKMEWalkMe$13.95$13.90$7.60▼$14.09$1.21B0.16438,095 shsN/ATen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVAXNovavax+9.53%+25.75%+18.38%+22.55%+69.92%WKMEWalkMe0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVAXNovavax 2.10Hold$12.1319.93% UpsideWKMEWalkMe 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NVAX and WKME Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026NVAXNovavax Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D)5/6/2026NVAXNovavax TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$8.00 ➝ $9.004/9/2026NVAXNovavax B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy3/12/2026NVAXNovavax Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)3/12/2026NVAXNovavax Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy2/27/2026NVAXNovavax HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$11.00 ➝ $16.00(Data available from 5/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVAXNovavax$596.34M2.79$3.51 per share2.88($0.88) per share-11.49WKMEWalkMe$266.95M4.53N/AN/A$3.00 per share4.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVAXNovavax$440.30M-$0.58N/AN/AN/A-14.73%-14.82%1.23%N/AWKMEWalkMe-$59.14M-$0.44N/AN/AN/A-16.55%-9.60%-5.43%N/ALatest NVAX and WKME EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026NVAXNovavax-$0.25-$0.06+$0.19-$0.06$79.81 million$118.90 million2/26/2026Q4 2025NVAXNovavax-$0.66$0.11+$0.77$0.11$90.26 million$136.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNVAXNovavaxN/AN/AN/AN/AN/AWKMEWalkMeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVAXNovavaxN/A2.482.10WKMEWalkMeN/A2.042.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVAXNovavax53.04%WKMEWalkMe70.91%Insider OwnershipCompanyInsider OwnershipNVAXNovavax1.00%WKMEWalkMe27.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVAXNovavax1,990164.44 million162.79 millionOptionableWKMEWalkMe1,21086.78 million62.86 millionNo DataNVAX and WKME HeadlinesRecent News About These CompaniesEnterprises Lose 51 Workdays Per Employee to Technology Friction Annually Despite Record AI Investment, WalkMe Global Study of 3,750 FindsApril 9, 2026 | globenewswire.comABeam Consulting Partners with WalkMe to Enhance Enterprise Management Services in Southeast AsiaApril 10, 2025 | businesswire.comCategory Creator WalkMe Recognized As The “AI-Powered DAP for the Enterprise” In Industry Analyst ReportNovember 26, 2024 | globenewswire.com3 Global Stocks to Diversify Your PortfolioOctober 25, 2024 | stocknews.comWalkMe Inc.: SAP Completes Acquisition of WalkMeSeptember 13, 2024 | finanznachrichten.deSAP Closes Acquisition Of WalkMeSeptember 13, 2024 | markets.businessinsider.comWhere are the Opportunities in (WKME)September 13, 2024 | news.stocktradersdaily.comNSAP Completes Acquisition of WalkMeSeptember 12, 2024 | globenewswire.com(WKME) Investment ReportAugust 28, 2024 | news.stocktradersdaily.comNWalkMe Doubles Down on AI Innovation, Releases Enhancements to Award-Winning Copilot, WalkMe(X)August 19, 2024 | globenewswire.comIsraeli software firm WalkMe to sublease space from Salesforce for U.S. HQAugust 16, 2024 | bizjournals.comNeedham Reaffirms Their Hold Rating on WalkMe (WKME)August 6, 2024 | markets.businessinsider.comCatalyst Watch: Disney earnings, Costco sales update, MicroStrategy split, and eyes on AI patentsAugust 3, 2024 | msn.comWalkMe Ltd Ordinary SharesAugust 2, 2024 | morningstar.comMWKME Stock Earnings: WalkMe Beats EPS, Misses Revenue for Q2 2024August 2, 2024 | investorplace.comWalkMe Inc.: WalkMe Ltd. Announces Second Quarter 2024 Financial ResultsAugust 2, 2024 | finanznachrichten.deArgus upgrades SAP to 'Buy' with target price of $240August 2, 2024 | msn.comWalkMe Ltd. Announces Second Quarter 2024 Financial ResultsAugust 1, 2024 | globenewswire.comTrading (WKME) With Integrated Risk ControlsJuly 25, 2024 | news.stocktradersdaily.comNDigital Adoption Professionals Emerge as Key Players in AI Transformation, New WalkMe Survey RevealsJuly 25, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVAX and WKME Company DescriptionsNovavax NASDAQ:NVAX$10.11 +0.88 (+9.53%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$10.32 +0.21 (+2.06%) As of 05/8/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.WalkMe NASDAQ:WKMEWalkMe Ltd. provides cloud-based digital adaption platform and associated professional services in the United States and internationally. The company's AI-driven digital adoption platform helps companies to effectively navigate change brought by technology, which stack, identifies, and delivers the personalized guidance and automation. In addition, the company WalkMe's platform is delivered via web, desktop or mobile and pre-packaged to support the key workflows. The company was formerly known as Make Tutorial Ltd. and changed its name to WalkMe Ltd. in March 2012. WalkMe Ltd. was incorporated in 2011 and is headquartered in Tel Aviv, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance 3 Under-The-Radar Small Caps Making New All-Time Highs Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
